ReviewViruses2021
Hantavirus Research in Finland: Highlights and Perspectives.
Review in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 29 citations in OpenAlex.
- Global threats and regional trends: Navigating the complex landscape of human orthohantavirus infections.Infectious diseases & immunity · 2026Review
- Hantavirus Seroprevalence in the Population of Saint Petersburg and the Leningrad Region, Russia.Viruses · 2026Article
- Article
- Review
- Ecological determinants driving orthohantavirus prevalence in small mammals of Europe: a systematic review.One health outlook · 2025Review
- Achievement and Challenges in Orthohantavirus Vaccines.Vaccines · 2025Review
- Genetic analysis implicates ERAP1 and HLA as risk factors for severe Puumala virus infection.Human molecular genetics · 2025Article
- Puumala orthohantavirus: prevalence, biology, disease, animal models and recent advances in therapeutics development and structural biology.Frontiers in immunology · 2025Review
- Hantavirus Research in Finland.Viruses · 2024Article
- DNA Vaccines Encoding HTNV GP-Derived Th Epitopes Benefited from a LAMP-Targeting Strategy and Established Cellular Immunoprotection.Vaccines · 2024Article
- Nephropathia Epidemica Caused by Puumala Virus in Bank Voles, Scania, Southern Sweden.Emerging infectious diseases · 2024Article
- Poor Prognosis for Puumala Virus Infections Predicted by Lymphopenia and Dyspnea.Emerging infectious diseases · 2023Article
- The impact of wildlife and environmental factors on hantavirus infection in the host and its translation into human risk.Proceedings. Biological sciences · 2023Article
- Article
- Article
- Meteorological change and hemorrhagic fever with renal syndrome epidemic in China, 2004-2018.Scientific reports · 2022Article
- Article
- Alcohol Consumption and Its Influence on the Clinical Picture of Puumala Hantavirus Infection.Viruses · 2022Article
- Severity Biomarkers in Puumala Hantavirus Infection.Viruses · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Finland has the highest incidence of hantavirus infections globally, with a significant impact on public health. The large coverage of boreal forests and the cyclic dynamics of the dominant forest rodent species, the bank vole
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.